glp-1 for psoriasis Emerging research suggests that GLP-1–based weight loss medications may offer dual benefits—supporting cardiovascular health while potentially improving by reducing systemic inflammation. Learn more : https://wb.md/4shrzWx GLP-1 Receptor Agonist Use for

Other studies suggest up to two-thirds of lost weight is regained within a year, significantly faster than seen in non-medicated, behavioural weight loss interventions

LIFT-AD Trial: Phase 2/3 Termination (September 2024) Despite the ACT-AD disappointment, Athira advanced to a larger phase 2/3 trial called LIFT-AD

Nopeptides support, but do not replace, foundational lifestyle changes

Some compounders use semaglutide sodium or semaglutide acetate instead of the exact semaglutide molecule used in FDA-approved drugs

DSIP + melatonin + Epitalon is a well-documented community sleep stack

Eli Lilly and Company press release, 2026